| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment
|
Nagata, Marino
|
|
|
70 |
8 |
p. 2301-2312
|
artikel
|
| 2 |
Activity of tumor-associated macrophage depletion by CSF1R blockade is highly dependent on the tumor model and timing of treatment
|
O’Brien, Sarah A.
|
|
|
70 |
8 |
p. 2401-2410
|
artikel
|
| 3 |
CAR19/22 T cell therapy in adult refractory Burkitt’s lymphoma
|
Zhou, Xiaoxi
|
|
|
70 |
8 |
p. 2379-2384
|
artikel
|
| 4 |
CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer
|
Lam, Jian Hang
|
|
|
70 |
8 |
p. 2353-2365
|
artikel
|
| 5 |
Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trials
|
Melssen, Marit M.
|
|
|
70 |
8 |
p. 2151-2164
|
artikel
|
| 6 |
Correction to: Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti‑B7H3 immunotherapy
|
Kramer, Kim
|
|
|
70 |
8 |
p. 2415
|
artikel
|
| 7 |
Correction to: Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
|
Sasidharan Nair, Varun
|
|
|
70 |
8 |
p. 2123
|
artikel
|
| 8 |
Correction to: The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta‑analysis
|
You, Yafei
|
|
|
70 |
8 |
p. 2337
|
artikel
|
| 9 |
Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors
|
Tyan, Kevin
|
|
|
70 |
8 |
p. 2209-2221
|
artikel
|
| 10 |
Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations
|
Liu, Qiaofei
|
|
|
70 |
8 |
p. 2165-2177
|
artikel
|
| 11 |
Immunotherapy response modeling by ex-vivo organ culture for lung cancer
|
Kamer, Iris
|
|
|
70 |
8 |
p. 2223-2234
|
artikel
|
| 12 |
Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis
|
Tsai, Yi-Fang
|
|
|
70 |
8 |
p. 2339-2351
|
artikel
|
| 13 |
LncRNA UCA1 attenuated the killing effect of cytotoxic CD8 + T cells on anaplastic thyroid carcinoma via miR-148a/PD-L1 pathway
|
Wang, Xiaoming
|
|
|
70 |
8 |
p. 2235-2245
|
artikel
|
| 14 |
Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer
|
Zanker, Damien J.
|
|
|
70 |
8 |
p. 2125-2138
|
artikel
|
| 15 |
Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy
|
Kramer, Kim
|
|
|
70 |
8 |
p. 2411-2414
|
artikel
|
| 16 |
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
|
Sasidharan Nair, Varun
|
|
|
70 |
8 |
p. 2103-2121
|
artikel
|
| 17 |
miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis
|
Meng, Fanyi
|
|
|
70 |
8 |
p. 2247-2259
|
artikel
|
| 18 |
Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden
|
Salehi-Rad, Ramin
|
|
|
70 |
8 |
p. 2389-2400
|
artikel
|
| 19 |
Pembrolizumab-induced immune-mediated fatal colitis with concurrent giardia infection
|
Sisman, Gurhan
|
|
|
70 |
8 |
p. 2385-2388
|
artikel
|
| 20 |
Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology
|
Hoa, Sabrina
|
|
|
70 |
8 |
p. 2197-2207
|
artikel
|
| 21 |
Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient
|
Zhong, Runbo
|
|
|
70 |
8 |
p. 2261-2274
|
artikel
|
| 22 |
Support of BCP-ALL-cells by autologous bone marrow Th-cells involves induction of AID expression but not widespread AID off-target mutagenesis
|
Traxel, Sabrina
|
|
|
70 |
8 |
p. 2275-2289
|
artikel
|
| 23 |
The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis
|
You, Yafei
|
|
|
70 |
8 |
p. 2323-2335
|
artikel
|
| 24 |
Therapeutic vaccination targeting CD40 and TLR3 controls melanoma growth through existing intratumoral CD8 T cells without new T cell infiltration
|
Stevens, Aaron D.
|
|
|
70 |
8 |
p. 2139-2150
|
artikel
|
| 25 |
The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer
|
Jiang, Long
|
|
|
70 |
8 |
p. 2313-2321
|
artikel
|
| 26 |
Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC
|
O’Melia, Meghan J.
|
|
|
70 |
8 |
p. 2179-2195
|
artikel
|
| 27 |
Tumor mutation score is more powerful than tumor mutation burden in predicting response to immunotherapy in non-small cell lung cancer
|
Li, Yuan
|
|
|
70 |
8 |
p. 2367-2378
|
artikel
|
| 28 |
T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model
|
Stahlie, Emma H. A.
|
|
|
70 |
8 |
p. 2291-2300
|
artikel
|
Tijdschrift beschrijving